CA
ZBH icon

Continuum Advisory’s Zimmer Biomet ZBH Stock Holding History

Continuum Advisory’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-280
Closed -$31.7K – 1620
2025
Q1 		$31.7K Sell
280
-117
-29% -$12.5K ﹤0.01% 773
2024
Q4 		$41.9K Buy
397
+7
+2% +$751 0.01% 694
2024
Q3 		$42.5K Sell
390
-22
-5% -$2.4K 0.01% 688
2024
Q2 		$44.7K Buy
412
+2
+0.5% +$236 0.01% 629
2024
Q1 		$49.8K Buy
+410
New +$51.2K 0.01% 600

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Continuum Advisory's ZBH Position: Q2 2025 in Review

Continuum Advisory sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 280 shares — an estimated $31.7K sold.

Continuum Advisory first reported a position in ZBH in Q1 2024 and held it in 5 quarters. The position peaked at $49.8K in Q1 2024. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • Continuum Advisory reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 280 Zimmer Biomet shares in Q2 2025, an estimated $31.7K.
  • Continuum Advisory first reported a position in Zimmer Biomet in Q1 2024 and held it in 5 quarters.
  • Continuum Advisory's Zimmer Biomet position peaked at $49.8K in Q1 2024.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.